Nenad Antic, MD
Hematology/Oncology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 34 years
- Graduated 1992
Offices
1 location · The Oncology Institute CA, A Professional Corporation · 114 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Antic’s office at (213) 246-2422 to ask if they take your plan before you enroll.
California Medical Board record
Licence C169820 · Current
Licensed to practise in California · since 2020 · expires 2028-08-31 · University of Belgrade School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Medical Oncology
Original Medicare doctor bills
$67,030
Medicare paid this office $67,030 for 85 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 32 | $2,352 | $59 |
| Return visit (30+ min) | 17 | $1,907 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $756 | $42 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 15 | $231 | $12 |
Who their Medicare patients are
85 Original Medicare patients in 2024. Average age 70 · Women 59% · Also on Medicaid 78% · Health risk score 2.15. Above the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 73% · Cancer 47% · Diabetes 46% · Coronary heart disease 29% · Heart failure 29% · Chronic kidney disease 27% · Depression 16%.
The office billed $198,097, Medicare allowed $86,125 and paid $67,030; for 2,612 services of 46 kinds; $54,077 of it was for drugs given in the office and $12,953 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 85 | 2,612 | 70 | 2.15 | $198,097 | $67,030 |
| 2023 | 96 | 3,293 | 71 | 1.75 | $107,556 | $38,994 |
| 2022 | 82 | 5,988 | 72 | 1.88 | $128,284 | $47,453 |
| 2021 | 62 | 1,901 | 71 | 1.95 | $80,223 | $32,460 |
| 2020 | 89 | 634 | 75 | 2.25 | $40,269 | $12,282 |
| 2019 | 140 | 422 | 74 | 2.11 | $53,382 | $20,123 |
| 2018 | 169 | 567 | 72 | 2.04 | $71,710 | $26,666 |
| 2017 | 139 | 5,301 | 72 | 1.54 | $241,595 | $98,284 |
| 2016 | 165 | 9,543 | 73 | 1.90 | $511,001 | $209,843 |
| 2015 | 161 | 11,015 | 74 | 1.92 | $631,348 | $255,971 |
| 2014 | 188 | 16,739 | 73 | 1.85 | $914,462 | $290,893 |
| 2013 | 218 | 15,182 | 73 | 1.85 | $943,851 | $239,051 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 54 | $4,934 | $63 |
| Return visit (30+ min) | 29 | $4,255 | $97 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $2,100 | $51 |
| Assessment of emotional or behavioral problems | 13 | $46 | $4 |
2022: 3 services
| Return visit (30+ min) | 21 | $3,941 | $99 |
| Short return visit (20+ min) | 33 | $3,342 | $66 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,792 | $56 |
2021: 4 services
| Telephone medical discussion with physician, 11-20 minutes | 20 | $2,844 | $79 |
| Short return visit (20+ min) | 22 | $2,736 | $72 |
| New patient visit (45+ min) | 16 | $1,891 | $118 |
| Return visit (30+ min) | 16 | $1,643 | $86 |
2020: 6 services
| Short return visit (20+ min) | 29 | $2,033 | $58 |
| New patient visit (45+ min) | 12 | $1,692 | $141 |
| Return visit (30+ min) | 12 | $1,237 | $95 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $822 | $63 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $630 | $37 |
| Insertion of needle into vein for collection of blood sample | 35 | $131 | $3 |
2019: 6 services
| Short return visit (20+ min) | 88 | $9,729 | $60 |
| Return visit (30+ min) | 28 | $4,133 | $92 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,231 | $88 |
| New patient visit (30+ min) | 12 | $1,070 | $89 |
| Short return visit | 15 | $535 | $33 |
| Insertion of needle into vein for collection of blood sample | 55 | $356 | $3 |
2018: 8 services
| Return visit (30+ min) | 57 | $9,399 | $78 |
| Short return visit (20+ min) | 76 | $6,356 | $55 |
| New patient visit (45+ min) | 18 | $2,371 | $132 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,655 | $87 |
| New patient visit (30+ min) | 15 | $1,333 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,047 | $62 |
| Short return visit | 20 | $753 | $31 |
| Insertion of needle into vein for collection of blood sample | 71 | $478 | $3 |
2017: 6 services
| Return visit (30+ min) | 88 | $13,527 | $78 |
| Short return visit (20+ min) | 53 | $4,339 | $54 |
| New patient visit (45+ min) | 18 | $2,259 | $125 |
| Insertion of needle into vein for collection of blood sample | 75 | $685 | $3 |
| Short return visit | 17 | $439 | $24 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $342 | $9 |
2016: 9 services
| Return visit (30+ min) | 101 | $16,781 | $82 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $6,514 | $109 |
| Short return visit (20+ min) | 64 | $4,527 | $52 |
| New patient visit (45+ min) | 21 | $2,804 | $134 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 12 | $1,842 | $25 |
| Short return visit | 23 | $901 | $36 |
| Insertion of needle into vein for collection of blood sample | 80 | $592 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 19 | $572 | $10 |
| Injection, ondansetron hydrochloride, per 1 mg | 11 | $40 | None |
2015: 7 services
| Return visit (30+ min) | 135 | $23,397 | $78 |
| Administration of chemotherapy into vein, 1 hour or less | 12 | $8,393 | $109 |
| New patient visit (45+ min) | 41 | $5,561 | $136 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 12 | $1,755 | $24 |
| Insertion of needle into vein for collection of blood sample | 83 | $617 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 19 | $505 | $10 |
| Injection, ondansetron hydrochloride, per 1 mg | 11 | $42 | None |
2014: 10 services
| Return visit (30+ min) | 163 | $31,135 | $78 |
| Administration of chemotherapy into vein, 1 hour or less | 18 | $21,175 | $107 |
| New patient visit (45+ min) | 36 | $4,921 | $137 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 19 | $4,785 | $25 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 23 | $1,426 | $10 |
| Insertion of needle into vein for collection of blood sample | 101 | $853 | $3 |
| Irrigation of implanted venous access drug delivery device | 12 | $348 | $18 |
| Injection, dexamethasone sodium phosphate, 1 mg | 14 | $245 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 16 | $127 | None |
| Injection, diphenhydramine hcl, up to 50 mg | 13 | $39 | None |
2013: 11 services
| Return visit (30+ min) | 181 | $37,624 | $83 |
| Administration of chemotherapy into vein, 1 hour or less | 25 | $24,265 | $114 |
| New patient visit (45+ min) | 45 | $5,676 | $126 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 25 | $5,346 | $26 |
| Administration of chemotherapy into vein, each additional hour | 19 | $4,117 | $26 |
| Injection of additional new drug or substance into vein | 17 | $2,141 | $19 |
| Insertion of needle into vein for collection of blood sample | 112 | $1,079 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 20 | $1,039 | $10 |
| Injection, ondansetron hydrochloride, per 1 mg | 23 | $329 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 22 | $220 | None |
| Injection, diphenhydramine hcl, up to 50 mg | 14 | $36 | None |
Medicaid work
$3,298 in 2024
Medicaid paid $3,298 for 773 billed services this clinician did in 2024, up to 77 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 145 | $1,220 |
| Short return visit (20+ min) | 336 | $1,183 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure) | 85 | $242 |
| New patient visit (45+ min) | 12 | $207 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 26 | $158 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 22 | $125 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 39 | $112 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 80 | $21 |
| Injection, ondansetron hydrochloride, per 1 mg | 14 | $19 |
| Injection, diphenhydramine hcl, up to 50 mg | 14 | $12 |
| 2024 | 773 | 10 | 77 | $3,298 |
| 2023 | 1,731 | 8 | 103 | $9,715 |
| 2022 | 745 | 7 | 62 | $4,266 |
| 2021 | 696 | 7 | 30 | $4,895 |
| 2020 | 26 | 1 | 14 | $275 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 754 | $4,016 |
| Return visit (30+ min) | 381 | $2,201 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 265 | $1,502 |
| New patient visit (45+ min) | 75 | $593 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure) | 78 | $469 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 77 | $465 |
| New patient visit (30+ min) | 39 | $386 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 62 | $83 |
2022
| Short return visit (20+ min) | 245 | $1,190 |
| Return visit (30+ min) | 157 | $1,186 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 216 | $1,145 |
| New patient visit (30+ min) | 35 | $269 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 37 | $248 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure) | 42 | $134 |
| Short return visit | 13 | $94 |
2021
| New patient visit (30+ min) | 81 | $1,739 |
| Short return visit (20+ min) | 222 | $936 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 108 | $885 |
| Return visit (30+ min) | 96 | $501 |
| New patient visit (45+ min) | 51 | $496 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure) | 84 | $217 |
| Short return visit | 54 | $120 |
2020
| New patient visit (45+ min) | 26 | $275 |
Drugs they prescribed that Part D paid
$1,670,747
Pharmacies billed $1,670,747 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (18 of 780) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.
588 generic and 192 brand-name prescriptions · $1,670,747 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Keytruda | 22 | $244,449 | $11,111 |
| Lupron Depot | 15 | $71,081 | $4,739 |
| Eliquis | 27 | $17,064 | $632 |
| Docetaxel | 11 | $1,965 | $179 |
| Letrozole | 101 | $1,935 | $19 |
See all 16 drugs
| Keytruda | 22 | $244,449 | $11,111 |
| Lupron Depot | 15 | $71,081 | $4,739 |
| Eliquis | 27 | $17,064 | $632 |
| Docetaxel | 11 | $1,965 | $179 |
| Letrozole | 101 | $1,935 | $19 |
| Ondansetron | 43 | $1,707 | $40 |
| Anastrozole | 58 | $910 | $16 |
| Zoledronic Acid | 13 | $744 | $57 |
| Dexamethasone | 30 | $617 | $21 |
| Carboplatin | 12 | $588 | $49 |
| Hydroxyurea | 24 | $378 | $16 |
| Prednisone | 45 | $207 | $5 |
| Bicalutamide | 16 | $164 | $10 |
| Alendronate | 21 | $74 | $4 |
| Tamsulosin | 16 | $51 | $3 |
| Folic Acid | 13 | $43 | $3 |
Year by year
| 2024 | 780 | 207 | 2% (18) | 25% | $1,670,747 |
| 2023 | 543 | 160 | 5% (25) | None | $899,684 |
| 2022 | 392 | 110 | 6% (22) | 21% | $754,136 |
| 2021 | 523 | 124 | 9% (47) | 23% | $794,633 |
| 2020 | 722 | 176 | 7% (51) | 27% | $1,884,735 |
| 2019 | 1,339 | 204 | 8% (103) | 21% | $2,795,719 |
| 2018 | 1,357 | 216 | 5% (72) | 20% | $2,744,887 |
| 2017 | 1,333 | 238 | 7% (90) | 20% | $2,780,474 |
| 2016 | 1,440 | 243 | 9% (125) | 17% | $1,921,946 |
| 2015 | 1,456 | 229 | 9% (137) | 18% | $2,557,882 |
| 2014 | 1,548 | 255 | 11% (173) | 19% | $1,676,116 |
| 2013 | 1,397 | 247 | 9% (124) | 13% | $701,310 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Imbruvica | 11 | $187,573 | $17,052 |
| Abiraterone Acetate | 14 | $81,384 | $5,813 |
| Bortezomib | 12 | $26,988 | $2,249 |
| Eliquis | 21 | $15,743 | $750 |
| Letrozole | 95 | $2,533 | $27 |
| Anastrozole | 30 | $1,175 | $39 |
| Hydroxyurea | 32 | $920 | $29 |
| Megestrol Acetate | 11 | $608 | $55 |
| Prochlorperazine Maleate | 21 | $460 | $22 |
| Prednisone | 44 | $456 | $10 |
| Ondansetron | 23 | $372 | $16 |
| Dexamethasone | 18 | $359 | $20 |
| Hydrocodone-Acetaminophen | 12 | $117 | $10 |
| Alendronate | 16 | $108 | $7 |
2022: 8 drugs
| Abiraterone Acetate | 12 | $65,397 | $5,450 |
| Eliquis | 17 | $9,054 | $533 |
| Letrozole | 82 | $2,056 | $25 |
| Hydroxyurea | 31 | $1,229 | $40 |
| Anastrozole | 14 | $289 | $21 |
| Bicalutamide | 16 | $209 | $13 |
| Alendronate | 13 | $91 | $7 |
| Prednisone | 15 | $78 | $5 |
2021: 17 drugs
| Imatinib Mesylate | 18 | $107,740 | $5,986 |
| Eliquis | 26 | $13,343 | $513 |
| Letrozole | 59 | $1,807 | $31 |
| Hydroxyurea | 22 | $1,363 | $62 |
| Tamoxifen Citrate | 14 | $650 | $46 |
| Hydrocodone-Acetaminophen | 18 | $431 | $24 |
| Ondansetron | 26 | $418 | $16 |
| Bicalutamide | 17 | $376 | $22 |
| Anastrozole | 13 | $371 | $29 |
| Dexamethasone | 16 | $353 | $22 |
| Prochlorperazine Maleate | 21 | $283 | $13 |
| Prednisone | 36 | $259 | $7 |
| Alendronate | 11 | $169 | $15 |
| Ondansetron | 16 | $71 | $4 |
| Diphenhydramine | 20 | $50 | $3 |
| Tramadol | 11 | $36 | $3 |
| Dexamethasone Sodium Phosphate | 12 | $33 | $3 |
2020: 19 drugs
| Revlimid | 31 | $514,681 | $16,603 |
| Pomalyst | 15 | $284,967 | $18,998 |
| Cabometyx | 12 | $252,395 | $21,033 |
| Thalomid | 20 | $169,510 | $8,476 |
| Jakafi | 11 | $162,930 | $14,812 |
| Imatinib Mesylate | 29 | $75,277 | $2,596 |
| Eliquis | 32 | $16,077 | $502 |
| Exemestane | 12 | $3,846 | $320 |
| Anagrelide | 18 | $3,827 | $213 |
| Letrozole | 105 | $3,161 | $30 |
| Tamoxifen Citrate | 40 | $2,401 | $60 |
| Hydroxyurea | 58 | $2,316 | $40 |
| Dexamethasone | 53 | $1,787 | $34 |
| Anastrozole | 37 | $572 | $15 |
| Hydrocodone-Acetaminophen | 19 | $435 | $23 |
| Bicalutamide | 14 | $350 | $25 |
| Gabapentin | 15 | $182 | $12 |
| Ondansetron | 15 | $174 | $12 |
| Prednisone | 25 | $173 | $7 |
2019: 28 drugs
| Revlimid | 85 | $1,315,260 | $15,474 |
| Pomalyst | 13 | $238,577 | $18,352 |
| Thalomid | 27 | $223,761 | $8,287 |
| Ibrance | 16 | $201,528 | $12,596 |
| Xtandi | 12 | $143,481 | $11,957 |
| Imatinib Mesylate | 53 | $101,527 | $1,916 |
| Sprycel | 12 | $97,506 | $8,126 |
| Gilotrif | 12 | $86,301 | $7,192 |
| Anagrelide | 43 | $13,521 | $314 |
| Eliquis | 22 | $9,459 | $430 |
| Creon | 12 | $5,282 | $440 |
| Hydroxyurea | 147 | $4,713 | $32 |
| Exemestane | 19 | $3,819 | $201 |
| Letrozole | 165 | $3,708 | $22 |
| Dexamethasone | 121 | $3,585 | $30 |
| Tamoxifen Citrate | 66 | $3,314 | $50 |
| Hydrocodone-Acetaminophen | 50 | $1,023 | $20 |
| Fentanyl | 13 | $984 | $76 |
| Anastrozole | 55 | $715 | $13 |
| Prochlorperazine Maleate | 20 | $430 | $21 |
| Megestrol Acetate | 11 | $427 | $39 |
| Prednisone | 61 | $415 | $7 |
| Potassium Chloride | 19 | $405 | $21 |
| Morphine Sulfate Er | 13 | $319 | $25 |
| Ondansetron | 32 | $291 | $9 |
| Omeprazole | 20 | $208 | $10 |
| Gabapentin | 12 | $137 | $11 |
| Meloxicam | 19 | $99 | $5 |
2018: 24 drugs
| Revlimid | 87 | $1,264,164 | $14,531 |
| Thalomid | 32 | $260,969 | $8,155 |
| Pomalyst | 11 | $186,198 | $16,927 |
| Kisqali | 12 | $136,149 | $11,346 |
| Votrient | 11 | $126,553 | $11,505 |
| Xtandi | 11 | $125,639 | $11,422 |
| Imatinib Mesylate | 43 | $109,440 | $2,545 |
| Gilotrif | 11 | $91,992 | $8,363 |
| Sprycel | 12 | $88,205 | $7,350 |
| Xarelto | 17 | $7,109 | $418 |
| Exemestane | 27 | $5,714 | $212 |
| Letrozole | 207 | $4,953 | $24 |
| Hydroxyurea | 145 | $4,767 | $33 |
| Anagrelide | 37 | $4,222 | $114 |
| Tamoxifen Citrate | 97 | $3,782 | $39 |
| Dexamethasone | 115 | $3,478 | $30 |
| Anastrozole | 76 | $960 | $13 |
| Hydrocodone-Acetaminophen | 41 | $656 | $16 |
| Ondansetron | 58 | $632 | $11 |
| Prednisone | 67 | $398 | $6 |
| Warfarin | 22 | $326 | $15 |
| Omeprazole | 26 | $282 | $11 |
| Gabapentin | 15 | $175 | $12 |
| Prochlorperazine Maleate | 14 | $112 | $8 |
2017: 25 drugs
| Revlimid | 61 | $775,719 | $12,717 |
| Pomalyst | 18 | $265,157 | $14,731 |
| Xtandi | 21 | $213,999 | $10,190 |
| Thalomid | 22 | $181,142 | $8,234 |
| Afinitor | 12 | $166,533 | $13,878 |
| Gleevec | 15 | $139,902 | $9,327 |
| Zytiga | 13 | $120,959 | $9,305 |
| Sprycel | 12 | $82,133 | $6,844 |
| Imatinib Mesylate | 12 | $73,006 | $6,084 |
| Exemestane | 27 | $5,734 | $212 |
| Letrozole | 242 | $4,946 | $20 |
| Tamoxifen Citrate | 134 | $4,873 | $36 |
| Hydroxyurea | 131 | $4,116 | $31 |
| Dexamethasone | 103 | $1,175 | $11 |
| Hydrocodone-Ibuprofen | 13 | $1,157 | $89 |
| Anastrozole | 94 | $1,122 | $12 |
| Oxycodone | 18 | $721 | $40 |
| Prednisone | 70 | $567 | $8 |
| Oxycodone-Acetaminophen | 13 | $478 | $37 |
| Anagrelide | 11 | $390 | $35 |
| Hydrocodone-Acetaminophen | 18 | $341 | $19 |
| Ondansetron | 31 | $323 | $10 |
| Warfarin | 13 | $197 | $15 |
| Alendronate | 25 | $152 | $6 |
| Prochlorperazine Maleate | 11 | $99 | $9 |
2016: 25 drugs
| Revlimid | 33 | $378,324 | $11,464 |
| Thalomid | 37 | $270,111 | $7,300 |
| Pomalyst | 13 | $172,574 | $13,275 |
| Bosulif | 13 | $157,347 | $12,104 |
| Afinitor | 11 | $125,412 | $11,401 |
| Zytiga | 12 | $103,717 | $8,643 |
| Promacta | 11 | $76,378 | $6,943 |
| Sprycel | 12 | $75,539 | $6,295 |
| Exemestane | 29 | $7,106 | $245 |
| Tamoxifen Citrate | 133 | $4,435 | $33 |
| Letrozole | 222 | $3,434 | $15 |
| Hydroxyurea | 113 | $2,826 | $25 |
| Anastrozole | 157 | $2,198 | $14 |
| Oxycodone | 30 | $1,426 | $48 |
| Ondansetron | 57 | $1,024 | $18 |
| Oxycodone-Acetaminophen | 13 | $832 | $64 |
| Hydrocodone-Acetaminophen | 27 | $807 | $30 |
| Dexamethasone | 86 | $767 | $9 |
| Megestrol Acetate | 12 | $680 | $57 |
| Prednisone | 92 | $632 | $7 |
| Omeprazole | 39 | $365 | $9 |
| Hydromorphone | 11 | $285 | $26 |
| Warfarin | 19 | $220 | $12 |
| Alendronate | 15 | $82 | $5 |
| Chlorhexidine Gluconate | 15 | $58 | $4 |
2015: 28 drugs
| Revlimid | 31 | $362,043 | $11,679 |
| Pomalyst | 19 | $230,329 | $12,123 |
| Gleevec | 19 | $213,923 | $11,259 |
| Thalomid | 21 | $156,412 | $7,448 |
| Bosulif | 13 | $140,138 | $10,780 |
| Sutent | 12 | $137,185 | $11,432 |
| Zytiga | 16 | $122,564 | $7,660 |
| Xtandi | 14 | $122,104 | $8,722 |
| Tarceva | 12 | $81,207 | $6,767 |
| Sprycel | 12 | $69,367 | $5,781 |
| Neupogen | 18 | $40,460 | $2,248 |
| Letrozole | 191 | $6,742 | $35 |
| Tamoxifen Citrate | 137 | $4,169 | $30 |
| Anastrozole | 192 | $3,615 | $19 |
| Hydroxyurea | 107 | $3,593 | $34 |
| Oxycodone | 34 | $1,715 | $50 |
| Ondansetron | 81 | $1,144 | $14 |
| Hydromorphone | 19 | $958 | $50 |
| Dexamethasone | 57 | $766 | $13 |
| Prednisone | 101 | $759 | $8 |
| Hydrocodone-Acetaminophen | 25 | $636 | $25 |
| Megestrol Acetate | 13 | $545 | $42 |
| Warfarin | 17 | $242 | $14 |
| Prochlorperazine Maleate | 14 | $188 | $13 |
| Omeprazole | 13 | $186 | $14 |
| Methadone | 19 | $184 | $10 |
| Gabapentin | 24 | $146 | $6 |
| Alendronate | 16 | $98 | $6 |
2014: 31 drugs
| Gleevec | 31 | $244,784 | $7,896 |
| Pomalyst | 20 | $225,963 | $11,298 |
| Revlimid | 20 | $215,881 | $10,794 |
| Zytiga | 24 | $169,890 | $7,079 |
| Afinitor | 13 | $120,370 | $9,259 |
| Bosulif | 12 | $111,998 | $9,333 |
| Xtandi | 13 | $107,673 | $8,283 |
| Thalomid | 12 | $79,751 | $6,646 |
| Tarceva | 11 | $68,469 | $6,224 |
| Neupogen | 18 | $35,025 | $1,946 |
| Letrozole | 181 | $7,067 | $39 |
| Anastrozole | 228 | $6,736 | $30 |
| Exemestane | 19 | $6,048 | $318 |
| Tamoxifen Citrate | 124 | $2,921 | $24 |
| Hydroxyurea | 97 | $2,604 | $27 |
| Fentanyl | 15 | $1,754 | $117 |
| Megestrol Acetate | 13 | $992 | $76 |
| Hydromorphone | 31 | $990 | $32 |
| Morphine Sulfate Er | 16 | $984 | $61 |
| Ondansetron | 106 | $966 | $9 |
| Hydrocodone-Acetaminophen | 35 | $766 | $22 |
| Oxycodone | 12 | $766 | $64 |
| Prednisone | 105 | $699 | $7 |
| Dexamethasone | 63 | $627 | $10 |
| Morphine Sulfate | 28 | $546 | $19 |
| Omeprazole | 12 | $317 | $26 |
| Alendronate | 25 | $218 | $9 |
| Warfarin | 17 | $207 | $12 |
| Prochlorperazine Maleate | 18 | $172 | $10 |
| Methadone | 23 | $116 | $5 |
| Gabapentin | 11 | $100 | $9 |
2013: 21 drugs
| Thalomid | 33 | $241,514 | $7,319 |
| Gleevec | 24 | $153,654 | $6,402 |
| Anastrozole | 369 | $10,607 | $29 |
| Letrozole | 142 | $6,424 | $45 |
| Exemestane | 29 | $5,626 | $194 |
| Hydroxyurea | 103 | $2,777 | $27 |
| Fentanyl | 18 | $2,630 | $146 |
| Tamoxifen Citrate | 156 | $2,627 | $17 |
| Megestrol Acetate | 18 | $1,427 | $79 |
| Hydromorphone | 23 | $1,045 | $45 |
| Ondansetron | 66 | $945 | $14 |
| Dexamethasone | 29 | $614 | $21 |
| Bicalutamide | 12 | $491 | $41 |
| Morphine Sulfate Er | 14 | $425 | $30 |
| Morphine Sulfate | 24 | $407 | $17 |
| Prednisone | 83 | $401 | $5 |
| Prochlorperazine Maleate | 19 | $254 | $13 |
| Hydrocodone-Acetaminophen | 14 | $220 | $16 |
| Alendronate | 17 | $131 | $8 |
| Allopurinol | 11 | $102 | $9 |
| Methadone | 11 | $56 | $5 |
Money from drug and device companies
$2,424 in 2025
| 2025 | 41 | 102 | None | $2,424 |
| 2024 | 42 | 164 | None | $3,724 |
| 2023 | 44 | 229 | None | $4,841 |
| 2022 | 37 | 139 | None | $2,891 |
| 2021 | 41 | 203 | None | $3,919 |
| 2020 | 18 | 32 | None | $629 |
| 2019 | 18 | 99 | None | $1,669 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Bosulif | $230 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $211 | 9 payments
|
| Novartis Pharmaceuticals | Scemblix | $124 | 7 payments
|
| Incyte | Jakafi | $115 | 5 payments
|
| Array Biopharma | Braftovi | $107 | 6 payments
|
| Janssen Biotech | Rybrevant | $100 | 5 payments
|
See all 101 published payments
| Array Biopharma | Meals · 2025-10-22 | Braftovi | $2 |
| Array Biopharma | Meals · 2025-10-22 | Braftovi | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-21 | Calquence | $27 |
| Iovance Biotherapeutics | Meals · 2025-10-21 | Amtagvi | $6 |
| Incyte | Meals · 2025-10-20 | Monjuvi | $24 |
| Genentech USA | Meals · 2025-10-16 | Itovebi | $26 |
| TerSera Therapeutics | Meals · 2025-10-16 | Zoladex | $33 |
| Puma Biotechnology | Meals · 2025-10-15 | Nerlynx | $24 |
| Merck Sharp & Dohme | Meals · 2025-10-14 | Keytruda | $28 |
| Alnylam Pharmaceuticals | Meals · 2025-10-09 | Givlaari | $28 |
| Azurity Pharmaceuticals | Meals · 2025-10-09 | Vivimusta | $16 |
| Stemline Therapeutics | Meals · 2025-10-07 | Orserdu | $30 |
| Novartis Pharmaceuticals | Meals · 2025-10-01 | Kisqali | $14 |
| Servier Pharmaceuticals | Meals · 2025-09-30 | Tibsovo | $36 |
| Astellas Pharma US | Meals · 2025-09-24 | Vyloy | $15 |
| Gilead Sciences | Meals · 2025-09-23 | Trodelvy | $23 |
| Incyte | Meals · 2025-09-22 | Jakafi | $16 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-20 | Stivarga | $17 |
| Lilly USA | Meals · 2025-09-17 | Verzenio | $17 |
| Abbvie | Meals · 2025-09-17 | Lupron Depot | $31 |
| Gilead Sciences | Meals · 2025-09-16 | Trodelvy | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-15 | Tagrisso | $34 |
| Pfizer | Meals · 2025-09-11 | Ibrance | $27 |
| Celgene | Meals · 2025-09-10 | Reblozyl | $30 |
| Pfizer | Meals · 2025-09-04 | Tivdak | $26 |
| Array Biopharma | Meals · 2025-09-03 | Braftovi | $19 |
| Array Biopharma | Meals · 2025-09-03 | Braftovi | $2 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-28 | Fruzaqla | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-27 | None | $21 |
| Lilly USA | Meals · 2025-08-26 | Verzenio | $17 |
| Sumitomo Pharma America | Meals · 2025-08-25 | Orgovyx | $20 |
| Janssen Biotech | Meals · 2025-08-22 | Tecvayli | $14 |
| Janssen Biotech | Meals · 2025-08-14 | Rybrevant | $25 |
| PharmaEssentia USA | Meals · 2025-08-13 | Besremi | $32 |
| BeOne Medicines USA | Meals · 2025-08-12 | Brukinsa | $23 |
| Pfizer | Meals · 2025-08-06 | Elrexfio | $26 |
| GlaxoSmithKline | Meals · 2025-08-05 | Ojjaara | $17 |
| Genmab U.S. | Meals · 2025-08-05 | Epkinly | $34 |
| Novartis Pharmaceuticals | Meals · 2025-08-04 | Scemblix | $24 |
| Abbvie | Meals · 2025-07-31 | Imbruvica | $14 |
| Abbvie | Meals · 2025-07-29 | Epkinly | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-29 | Enhertu | $20 |
| Incyte | Meals · 2025-07-21 | Jakafi | $26 |
| Incyte | Meals · 2025-07-15 | Zynyz | $24 |
| Blueprint Medicines | Meals · 2025-07-15 | Ayvakit | $26 |
| Genmab U.S. | Meals · 2025-07-10 | Epkinly | $35 |
| Sobi | Meals · 2025-07-09 | Doptelet | $25 |
| Novartis Pharmaceuticals | Meals · 2025-06-26 | Fabhalta | $16 |
| Sumitomo Pharma America | Meals · 2025-06-25 | Orgovyx | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-23 | Advate | $25 |
| Alexion Pharmaceuticals | Meals · 2025-06-19 | Ultomiris | $25 |
| Incyte | Meals · 2025-06-17 | Jakafi | $24 |
| Gilead Sciences | Meals · 2025-06-17 | Trodelvy | $20 |
| Novartis Pharmaceuticals | Meals · 2025-06-16 | Kisqali | $18 |
| Pfizer | Meals · 2025-06-10 | Ibrance | $22 |
| Array Biopharma | Meals · 2025-06-09 | Braftovi | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-05 | Imfinzi | $27 |
| Dendreon Pharmaceuticals | Meals · 2025-06-04 | Provenge | $34 |
| Pfizer | Meals · 2025-06-03 | Tivdak | $25 |
| Daiichi Sankyo | Meals · 2025-06-02 | Enhertu | $21 |
| Recordati Rare Diseases Inc. | Meals · 2025-05-30 | Sylvant | $25 |
| Janssen Biotech | Meals · 2025-05-20 | Carvykti | $24 |
| BeOne Medicines USA | Meals · 2025-05-12 | Brukinsa | $37 |
| Recordati Rare Diseases Inc. | Meals · 2025-05-08 | Enjaymo | $29 |
| Pfizer | Meals · 2025-05-07 | Adcetris | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-01 | Imfinzi | $32 |
| PharmaEssentia USA | Meals · 2025-04-30 | Besremi | $34 |
| Daiichi Sankyo | Meals · 2025-04-29 | Enhertu | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-23 | Enhertu | $21 |
| Janssen Biotech | Meals · 2025-04-22 | Rybrevant | $17 |
| Novartis Pharmaceuticals | Meals · 2025-04-09 | Scemblix | $20 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-03 | Stivarga | $19 |
| Merck Sharp & Dohme | Meals · 2025-04-02 | Keytruda | $28 |
| Eisai | Meals · 2025-03-27 | Lenvima | $27 |
| Pfizer | Meals · 2025-03-24 | Bosulif | $26 |
| Pfizer | Meals · 2025-03-18 | Xtandi | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-17 | Opdivo | $20 |
| Agios Pharmaceuticals | Meals · 2025-03-13 | Pyrukynd | $33 |
| Gilead Sciences | Meals · 2025-03-11 | Trodelvy | $22 |
| Karyopharm Therapeutics | Meals · 2025-03-06 | Xpovio | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-04 | None | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-26 | Nubeqa | $30 |
| Merck Sharp & Dohme | Meals · 2025-02-25 | Welireg | $29 |
| Lilly USA | Meals · 2025-02-24 | Verzenio | $32 |
| Lilly USA | Meals · 2025-02-20 | Verzenio | $19 |
| Stemline Therapeutics | Meals · 2025-02-19 | Orserdu | $30 |
| Boston Scientific | Meals · 2025-02-17 | Therasphere Y90 Glass Microspheres 10 Gbq | $45 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-13 | None | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-11 | None | $32 |
| Novartis Pharmaceuticals | Meals · 2025-02-10 | Kisqali | $16 |
| Geron | Meals · 2025-02-05 | Rytelo | $30 |
| Daiichi Sankyo | Meals · 2025-02-04 | Vanflyta | $29 |
| GlaxoSmithKline | Meals · 2025-01-29 | Jemperli | $20 |
| Celgene | Meals · 2025-01-28 | Pomalyst | $33 |
| Janssen Biotech | Meals · 2025-01-27 | Rybrevant | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-23 | Imfinzi | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-23 | Imfinzi | $2 |
| Array Biopharma | Meals · 2025-01-14 | Braftovi | $29 |
| Pfizer | Meals · 2025-01-13 | Bosulif | $26 |
| Novartis Pharmaceuticals | Meals · 2025-01-09 | Scemblix | $16 |
| Legend Biotech USA | Meals · 2025-01-08 | Carvykti | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,724
| Novartis Pharmaceuticals | Scemblix | $391 | 18 payments
|
| Janssen Biotech | Darzalex | $358 | 15 payments
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $316 | 15 payments
|
| Eisai | Lenvima | $236 | 9 payments
|
| Daiichi Sankyo | Enhertu | $214 | 10 payments
|
| Alexion Pharmaceuticals | Ultomiris | $197 | 7 payments
|
| Pfizer | Ibrance | $180 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $174 | 12 payments
|
| Takeda Pharmaceuticals U.S.A. | Fruzaqla | $154 | 6 payments
|
| Incyte | Monjuvi | $140 | 3 payments
|
| Lilly USA | Verzenio | $111 | 5 payments
|
| Merck Sharp & Dohme | Keytruda | $102 | 4 payments
|
| Array Biopharma | Lorbrena | $80 | 3 payments
|
| Genzyme | Sarclisa | $71 | 3 payments
|
| Abbvie | Epkinly | $67 | 3 payments
|
| Astellas Pharma US | Xospata | $65 | 3 payments
|
| Gilead Sciences | None | $60 | 2 payments
|
| Genentech USA | Phesgo | $56 | 2 payments
|
| Aveo Pharmaceuticals | Fotivda | $55 | 2 payments
|
| ADC Therapeutics America | None | $53 | 2 payments
|
| Puma Biotechnology | None | $51 | 2 payments
|
| EMD Serono | None | $43 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Stivarga | $41 | 2 payments
|
| Taiho Oncology | Lonsurf | $41 | 2 payments
|
| GlaxoSmithKline | Jemperli | $40 | 2 payments
|
| Mirati Therapeutics | Krazati | $36 | 2 payments
|
| Immunocore | Kimmtrak | $34 | 1 payment
|
| Genmab U.S. | Epkinly | $33 | 1 payment
|
| BeiGene USA | Brukinsa | $33 | 1 payment
|
| Sobi | Doptelet | $32 | 1 payment
|
| Agios Pharmaceuticals | Pyrukynd | $32 | 2 payments
|
| Celgene | Reblozyl | $32 | 1 payment
|
| Tempus AI | None | $29 | 1 payment
|
| Exelixis | Cabometyx | $25 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $24 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $20 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $19 | 1 payment
|
| Blueprint Medicines | Ayvakit | $18 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $18 | 1 payment
|
| Ipsen Biopharmaceuticals | Onivyde | $17 | 1 payment
|
| Sumitomo Pharma America | Orgovyx | $16 | 1 payment
|
| Tolmar | Eligard | $13 | 1 payment
|
2023: $4,841
| Janssen Biotech | Imbruvica | $423 | 18 payments
|
| Novartis Pharmaceuticals | Scemblix | $419 | 24 payments
|
| Merck Sharp & Dohme | Keytruda | $397 | 17 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $272 | 18 payments
|
| Gilead Sciences | Trodelvy | $252 | 12 payments
|
| Daiichi Sankyo | Enhertu | $248 | 12 payments
|
| Pfizer | Ibrance | $221 | 12 payments
|
| Eisai | Lenvima | $202 | 11 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $198 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $196 | 9 payments
|
| GlaxoSmithKline | Zejula | $160 | 9 payments
|
| Astellas Pharma US | Xospata | $146 | 3 payments
|
| Celgene | Reblozyl | $128 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Stivarga | $122 | 5 payments
|
| Seagen | Tukysa | $111 | 4 payments
|
| AbbVie | Venclexta | $110 | 5 payments
|
| Puma Biotechnology | None | $103 | 4 payments
|
| Alexion Pharmaceuticals | Ultomiris | $91 | 4 payments
|
| Amgen | Lumakras | $71 | 4 payments
|
| MorphoSys US | Monjuvi | $68 | 3 payments
|
| PharmaEssentia USA | Besremi | $63 | 3 payments
|
| Mirati Therapeutics | Krazati | $61 | 3 payments
|
| Stemline Therapeutics | Orserdu | $60 | 3 payments
|
| ADC Therapeutics America | None | $56 | 2 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $54 | 2 payments
|
| Incyte | Monjuvi | $51 | 2 payments
|
| Kite Pharma | Yescarta | $51 | 2 payments
|
| Taiho Oncology | Lonsurf | $47 | 2 payments
|
| Genentech USA | Venclexta | $47 | 2 payments
|
| Lilly USA | Verzenio | $46 | 2 payments
|
| Genzyme | Enjaymo | $45 | 2 payments
|
| Rigel Pharmaceuticals | Rezlidhia | $39 | 2 payments
|
| Agios Pharmaceuticals | Pyrukynd | $37 | 2 payments
|
| TerSera Therapeutics | Xermelo | $36 | 1 payment
|
| Boston Scientific | Bodyguardian | $28 | 1 payment
|
| Sobi | Doptelet | $27 | 1 payment
|
| Tolmar | Eligard | $26 | 1 payment
|
| EMD Serono | Bavencio | $25 | 1 payment
|
| Sumitomo Pharma America | Orgovyx | $21 | 1 payment
|
| Blueprint Medicines | Ayvakit | $21 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $19 | 1 payment
|
| Ipsen Biopharmaceuticals | Onivyde | $16 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $14 | 1 payment
|
| Cumberland Pharmaceuticals | Sancuso | $13 | 1 payment
|
2022: $2,891
| Takeda Pharmaceuticals U.S.A. | Iclusig | $279 | 8 payments
|
| Janssen Biotech | Erleada | $248 | 9 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $235 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Calquence | $223 | 11 payments
|
| Novartis Pharmaceuticals | Scemblix | $188 | 11 payments
|
| Celgene | Onureg | $155 | 8 payments
|
| Merck Sharp & Dohme | Keytruda | $134 | 7 payments
|
| Eisai | Lenvima | $124 | 7 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $109 | 4 payments
|
| Amgen | Lumakras | $107 | 5 payments
|
| Bayer HealthCare Pharmaceuticals | Stivarga | $93 | 4 payments
|
| Karyopharm Therapeutics | Xpovio | $82 | 3 payments
|
| Jazz Pharmaceuticals | Zepzelca | $72 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $71 | 3 payments
|
| Genzyme | Sarclisa | $69 | 3 payments
|
| Seagen | Adcetris | $69 | 3 payments
|
| Incyte | Monjuvi | $68 | 3 payments
|
| Lilly USA | Verzenio | $67 | 3 payments
|
| Pfizer | Bosulif | $62 | 3 payments
|
| Kite Pharma | None | $51 | 2 payments
|
| Gilead Sciences | Trodelvy | $40 | 2 payments
|
| GE HealthCare | None | $39 | 2 payments
|
| TerSera Therapeutics | Xermelo | $33 | 1 payment
|
| Blueprint Medicines | Ayvakit | $27 | 1 payment
|
| Astellas Pharma US | Xospata | $24 | 1 payment
|
| Puma Biotechnology | Nerlynx | $24 | 1 payment
|
| Epizyme | Tazverik | $22 | 1 payment
|
| GlaxoSmithKline | Blenrep | $22 | 1 payment
|
| Sobi | Doptelet | $20 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $20 | 1 payment
|
| MorphoSys US | Monjuvi | $18 | 1 payment
|
| Emmaus Medical | Endari | $18 | 1 payment
|
| Mylan Institutional | Ogivri | $17 | 1 payment
|
| EMD Serono | None | $17 | 1 payment
|
| PharmaEssentia USA | Besremi | $16 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $15 | 1 payment
|
| Foundation Medicine | Foundationone | $15 | 1 payment
|
2021: $3,919
| Pharmacyclics LLC An AbbVie | Imbruvica | $298 | 12 payments
|
| Pfizer | Inlyta | $269 | 16 payments
|
| Seagen | Adcetris | $265 | 8 payments
|
| Astellas Pharma US | Xtandi | $241 | 8 payments
|
| GlaxoSmithKline | Zejula | $237 | 9 payments
|
| Novartis Pharmaceuticals | Mekinist | $229 | 13 payments
|
| Amgen | Lumakras | $227 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $217 | 17 payments
|
| Incyte | Jakafi | $188 | 13 payments
|
| Merck Sharp & Dohme | Keytruda | $153 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $133 | 8 payments
|
| Genzyme | Sarclisa | $119 | 6 payments
|
| Exelixis | Cabometyx | $117 | 5 payments
|
| Kite Pharma | None | $101 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Exkivity | $81 | 3 payments
|
| Blueprint Medicines | Gavreto | $77 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $77 | 5 payments
|
| Global Blood Therapeutics | Oxbryta | $75 | 4 payments
|
| EUSA Pharma (US) | Sylvant | $68 | 4 payments
|
| Eisai | Lenvima | $55 | 3 payments
|
| Celgene | Pomalyst | $55 | 3 payments
|
| Taiho Oncology | Inqovi | $51 | 2 payments
|
| Janssen Biotech | Darzalex | $50 | 2 payments
|
| Lilly USA | Verzenio | $48 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $48 | 2 payments
|
| Dova Pharmaceuticals | Doptelet | $40 | 2 payments
|
| Myriad Genetic Laboratories | Myrisk | $40 | 2 payments
|
| EMD Serono | None | $39 | 2 payments
|
| Genentech USA | Tecentriq | $36 | 2 payments
|
| Rigel Pharmaceuticals | Tavalisse | $34 | 2 payments
|
| Dendreon Pharmaceuticals | Provenge | $33 | 1 payment
|
| Jazz Pharmaceuticals | Vyxeos | $28 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $28 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $23 | 1 payment
|
| Acrotech Biopharma | Hemady | $22 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Stivarga | $22 | 1 payment
|
| MorphoSys US | Monjuvi | $21 | 1 payment
|
| Novo Nordisk | Esperoct | $21 | 1 payment
|
| Emmaus Medical | Endari | $18 | 1 payment
|
| Daiichi Sankyo | Enhertu | $18 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $16 | 1 payment
|
2020: $629
| Puma Biotechnology | Nerlynx | $55 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $51 | 3 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $47 | 2 payments
|
| Novartis Pharmaceuticals | Kisqali | $47 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $45 | 3 payments
|
| Daiichi Sankyo | Enhertu | $42 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $38 | 2 payments
|
| Global Blood Therapeutics | Oxbryta | $36 | 2 payments
|
| Incyte | Jakafi | $36 | 2 payments
|
| Emmaus Medical | Endari | $35 | 2 payments
|
| Janssen Biotech | Erleada | $34 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $33 | 1 payment
|
| Amgen | Blincyto | $28 | 1 payment
|
| Pfizer | Inlyta | $26 | 2 payments
|
| Lilly USA | Verzenio | $22 | 1 payment
|
| Genzyme | Cablivi | $20 | 1 payment
|
| GlaxoSmithKline | Blenrep | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $18 | 1 payment
|
2019: $1,669
| Celgene | Revlimid | $248 | 11 payments
|
| Pfizer | Bosulif | $223 | 16 payments
|
| Merck Sharp & Dohme | Keytruda | $218 | 17 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $198 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $159 | 9 payments
|
| Rigel Pharmaceuticals | Tavalisse | $122 | 5 payments
|
| Astellas Pharma US | None | $100 | 1 payment
|
| Genentech USA | Tecentriq | $98 | 5 payments
|
| Novartis Pharmaceuticals | Kisqali | $81 | 5 payments
|
| Dova Pharmaceuticals | Doptelet | $54 | 3 payments
|
| Puma Biotechnology | Nerlynx | $39 | 2 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $35 | 2 payments
|
| Verastem | Copiktra | $21 | 1 payment
|
| Lilly USA | Cyramza | $19 | 1 payment
|
| Taiho Oncology | Lonsurf | $15 | 1 payment
|
| Incyte | Jakafi | $13 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $12 | 1 payment
|
| Janssen Biotech | Balversa | $12 | 1 payment
|
Professional record
- NPI
- 1346293883
- Licence
- AZ 31592, CA 169820California C169820: Current · expires 2028-08-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- AZ 112600
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X)
- Mailing address
- 18000 Studebaker Rd Ste 800, Cerritos, CA, 90703
- NPI first listed
- 2006-05-18
- NPI last updated
- 2020-08-17
- NPI record certified
- 2020-08-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5750 W Thunderbird Rd, Glendale, AZ, 85306